NVRO - Nevro Medical Market Value

Nevro Corp. (NVRO) is currently reviewing its logistics and costs to maintain profitability in its core medtech segment amid market stagnation. The business relies on exclusive neurostimulation patents and surgical support while navigating strict FDA oversight. This price chart featuring the 0.22 metric confirms the company's resilience, as demand for pain management remains independent of economic conditions and demographic declines.

NVRO Nevro Corp: Market Value in the range 07/04/2022 - 04/13/2025

Comprehensive metric breakdowns and analytics for Nevro Medical (NVRO)

- stock price and consensus target price:

Stock Quotes Nevro|NVRO - Price Target Chart

- market capitalization statistics:

Market Value Nevro Medical|NVRO - Value Adjusted for Debt and Cash

- book value of equity indicators:

Net Assets per Single Share Nevro|NVRO - Total Stockholders' Equity|Market Cap to Net Assets Ratio nevro.com|NVRO - Aggregate Business Assets

- debt and solvency information:

- business earnings and investment ratios data:

NVRO - Profit After Tax|Projected Future Earnings Nevro Corp.|NVRO - Market Cap to Earnings|Projected Price to Earnings Nevro Corporation|NVRO - PEG Multiple|Enterprise Value to EBITDA Ratio Nevro Medical|NVRO - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Nevro|NVRO - Net earnings per share for the last four quarters|Quarterly EPS earnings growth nevro.com|NVRO - Net earnings per share growth this year|Expected earnings per share growth for next year Nevro Corp.

Initial company analysis:NVRO (Nevro)

Market capitalization reflects the aggregate value of all shares, determining the current market valuation of the business. This indicator is critical for portfolio stress-testing during a sharp capital outflow from risk assets. By analyzing the capitalization dynamics of a public company, an investor identifies the overvaluation of resources. For Nevro Corp. (NVRO), this trend is driven by a loss of pricing power. Declining margins due to hospital discounts directly limit the growth of the business value.

Key competitors